334 related articles for article (PubMed ID: 30951826)
1. Emerging role of PI3K/AKT in tumor-related epigenetic regulation.
Yang Q; Jiang W; Hou P
Semin Cancer Biol; 2019 Dec; 59():112-124. PubMed ID: 30951826
[TBL] [Abstract][Full Text] [Related]
2. Akt in cancer: Mediator and more.
Revathidevi S; Munirajan AK
Semin Cancer Biol; 2019 Dec; 59():80-91. PubMed ID: 31173856
[TBL] [Abstract][Full Text] [Related]
3. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer.
Spangle JM; Roberts TM; Zhao JJ
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):123-131. PubMed ID: 28315368
[TBL] [Abstract][Full Text] [Related]
5. PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond.
Fattahi S; Amjadi-Moheb F; Tabaripour R; Ashrafi GH; Akhavan-Niaki H
Life Sci; 2020 Dec; 262():118513. PubMed ID: 33011222
[TBL] [Abstract][Full Text] [Related]
6. Cigarette sidestream smoke induces histone H3 phosphorylation via JNK and PI3K/Akt pathways, leading to the expression of proto-oncogenes.
Ibuki Y; Toyooka T; Zhao X; Yoshida I
Carcinogenesis; 2014 Jun; 35(6):1228-37. PubMed ID: 24398671
[TBL] [Abstract][Full Text] [Related]
7. Fine-tuning AKT kinase activity through direct lysine methylation.
Guo J; Wei W
Cell Cycle; 2019 May; 18(9):917-922. PubMed ID: 31050579
[TBL] [Abstract][Full Text] [Related]
8. [Research advances on the relationship of PI3-kinase/Akt/mTOR pathway and epigenetic modification].
Wang X; Sun DF; Fang JY
Yi Chuan; 2006 Dec; 28(12):1585-90. PubMed ID: 17138547
[TBL] [Abstract][Full Text] [Related]
9. Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma.
Huang KH; Huang SF; Chen IH; Liao CT; Wang HM; Hsieh LL
Clin Cancer Res; 2009 Jun; 15(12):4174-80. PubMed ID: 19509163
[TBL] [Abstract][Full Text] [Related]
10. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
11. Histone acetylation: a key determinant of acquired cisplatin resistance in cancer.
Natu A; Verma T; Khade B; Thorat R; Gera P; Dhara S; Gupta S
Clin Epigenetics; 2024 Jan; 16(1):8. PubMed ID: 38172984
[TBL] [Abstract][Full Text] [Related]
12. Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance.
Ediriweera MK; Tennekoon KH; Samarakoon SR
Semin Cancer Biol; 2019 Dec; 59():147-160. PubMed ID: 31128298
[TBL] [Abstract][Full Text] [Related]
13. PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer.
Spangle JM; Dreijerink KM; Groner AC; Cheng H; Ohlson CE; Reyes J; Lin CY; Bradner J; Zhao JJ; Roberts TM; Brown M
Cell Rep; 2016 Jun; 15(12):2692-704. PubMed ID: 27292631
[TBL] [Abstract][Full Text] [Related]
14. Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis.
Martelli AM; Cocco L; Capitani S; Miscia S; Papa S; Manzoli FA
Eur J Histochem; 2007; 51 Suppl 1():125-31. PubMed ID: 17703603
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
16. Histone methylation modifiers in cellular signaling pathways.
Alam H; Gu B; Lee MG
Cell Mol Life Sci; 2015 Dec; 72(23):4577-92. PubMed ID: 26305020
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing mediated through activated PI3K/AKT signaling in breast cancer.
Zuo T; Liu TM; Lan X; Weng YI; Shen R; Gu F; Huang YW; Liyanarachchi S; Deatherage DE; Hsu PY; Taslim C; Ramaswamy B; Shapiro CL; Lin HJ; Cheng AS; Jin VX; Huang TH
Cancer Res; 2011 Mar; 71(5):1752-62. PubMed ID: 21216892
[TBL] [Abstract][Full Text] [Related]
18. PI3K signaling in cancer: beyond AKT.
Lien EC; Dibble CC; Toker A
Curr Opin Cell Biol; 2017 Apr; 45():62-71. PubMed ID: 28343126
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation.
Toulany M; Rodemann HP
Semin Cancer Biol; 2015 Dec; 35():180-90. PubMed ID: 26192967
[TBL] [Abstract][Full Text] [Related]
20. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications.
Carnero A; Blanco-Aparicio C; Renner O; Link W; Leal JF
Curr Cancer Drug Targets; 2008 May; 8(3):187-98. PubMed ID: 18473732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
